Works matching DE "CASTRATION-resistant prostate cancer"
Results: 2790
Influence of dosimetry accuracy on the correlation with treatment outcome in a preliminary PSMA radiopharmaceutical therapy study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 5, p. 1649, doi. 10.1007/s00259-024-07010-3
- By:
- Publication type:
- Article
Prostate‐specific antigen kinetics in Asian patients with metastatic castration‐sensitive prostate cancer treated with apalutamide in the TITAN trial: A post hoc analysis.
- Published in:
- International Journal of Urology, 2025, v. 32, n. 2, p. 164, doi. 10.1111/iju.15615
- By:
- Publication type:
- Article
Optimal use, combinations, and sequencing of therapies in advanced prostate cancer.
- Published in:
- Expert Review of Clinical Pharmacology, 2025, v. 18, n. 1/2, p. 13, doi. 10.1080/17512433.2025.2451643
- By:
- Publication type:
- Article
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors.
- Published in:
- CA: A Cancer Journal for Clinicians, 2025, v. 75, n. 2, p. 141, doi. 10.3322/caac.21870
- By:
- Publication type:
- Article
An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 12, p. 1221, doi. 10.1080/14737140.2024.2445152
- By:
- Publication type:
- Article
Current uses and resistance mechanisms of enzalutamide in prostate cancer treatment.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 11, p. 1085, doi. 10.1080/14737140.2024.2405103
- By:
- Publication type:
- Article
Drug–drug interaction potential among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) treated with novel androgen receptor inhibitors.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 5, p. 325, doi. 10.1080/14737140.2024.2328778
- By:
- Publication type:
- Article
Editorial Comment on "Changes in the treatment landscape of metastatic hormone‐sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study".
- Published in:
- International Journal of Urology, 2025, v. 32, n. 3, p. 321, doi. 10.1111/iju.15682
- By:
- Publication type:
- Article
Triplet therapy for metastatic castration‐sensitive prostate cancer: Rationale and clinical evidence.
- Published in:
- International Journal of Urology, 2025, v. 32, n. 3, p. 239, doi. 10.1111/iju.15647
- By:
- Publication type:
- Article
Recent advances in basic research on prostate cancer: Where we are heading?
- Published in:
- International Journal of Urology, 2025, v. 32, n. 3, p. 219, doi. 10.1111/iju.15628
- By:
- Publication type:
- Article
Serum CDC42 level change during abiraterone plus prednisone treatment and its association with prognosis in metastatic castration-resistant prostate cancer patients.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02130-0
- By:
- Publication type:
- Article
The prognostic role of systemic immune-inflammation index, SII, in Metastatic Castration-Resistant Prostate Cancer patients.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02084-3
- By:
- Publication type:
- Article
The efficacy and safety of <sup>225</sup>Ac-PSMA-617 in metastatic castration-resistant prostate cancer.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1516860
- By:
- Publication type:
- Article
Unleashing the power of peptides in prostate cancer immunotherapy: mechanism, facts and perspectives.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1478331
- By:
- Publication type:
- Article
Treatment of metastatic castration-resistant prostate cancer: review of current evidence and synthesis of expert opinions on radioligand therapy.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1530580
- By:
- Publication type:
- Article
Activity of 177Lu-PSMA-617 in Patients With Advanced Prostate Cancer and Brain Metastases.
- Published in:
- Clinical Genitourinary Cancer, 2025, v. 23, n. 2, p. N.PAG, doi. 10.1016/j.clgc.2025.102309
- By:
- Publication type:
- Article
Racial Differences in Survival and Healthcare Resource Utilization Among Medicaid-Insured Adults With Metastatic Prostate Cancer.
- Published in:
- Clinical Genitourinary Cancer, 2025, v. 23, n. 2, p. N.PAG, doi. 10.1016/j.clgc.2024.102291
- By:
- Publication type:
- Article
Virtual Tumor Board. Case discussion: Low-volume recurrent mCSPC.
- Published in:
- Urology Times, 2025, v. 53, n. 2, p. 26
- Publication type:
- Article
Health-related QOL is comparable among ARPI regimens for CSPC.
- Published in:
- Urology Times, 2025, v. 53, n. 2, p. 23
- By:
- Publication type:
- Article
Conference Highlights. 25TH ANNUAL MEETING OF THE SOCIETY OF UROLOGIC ONCOLOGY.
- Published in:
- 2025
- By:
- Publication type:
- Abstract
Prognostic Role of Prostate-specific Antigen Isoforms and Their Early Kinetics in Patients With Metastatic Castration-resistant Prostate Cancer Receiving New Generation Androgen Receptor Targeted Agents.
- Published in:
- In Vivo, 2025, v. 39, n. 2, p. 859, doi. 10.21873/invivo.13889
- By:
- Publication type:
- Article
RECIP 1.0 + PSA for response assessment in mCRPC patients treated with <sup>225</sup>Ac / <sup>177</sup>Lu PSMA combination therapy.
- Published in:
- EJNMMI Research, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13550-025-01211-z
- By:
- Publication type:
- Article
Physician and Patient Preferences for the Treatment of Metastatic Castration-Sensitive and Castration-Resistant Prostate Cancer: A Best-Worst Scaling Study in Japan.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 217, doi. 10.1007/s40487-025-00326-6
- By:
- Publication type:
- Article
ARv7 promotes the escape of prostate cancer cells from androgen deprivation therapy-induced senescence by mediating the SKP2/p27 axis.
- Published in:
- BMC Biology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12915-025-02172-4
- By:
- Publication type:
- Article
miRNA Signatures as Predictors of Therapy Response in Castration-Resistant Prostate Cancer: Insights from Clinical Liquid Biopsies and 3D Culture Models.
- Published in:
- Genes, 2025, v. 16, n. 2, p. 180, doi. 10.3390/genes16020180
- By:
- Publication type:
- Article
Cell Models of Castration Resistant and High Dose Testosterone-Resistant Prostate Cancer Recapitulate the Heterogeneity of Response Observed in Clinical Practice.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 593, doi. 10.3390/cancers17040593
- By:
- Publication type:
- Article
The Tight Relationship Between the Tumoral Microenvironment and Radium-223.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 456, doi. 10.3390/biomedicines13020456
- By:
- Publication type:
- Article
Natural Compounds and Histone Deacetylase Inhibitors: A Combined Approach Against mCRPC Cells.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 296, doi. 10.3390/biomedicines13020296
- By:
- Publication type:
- Article
Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1542811
- By:
- Publication type:
- Article
Co-modulation of a circular form of PCDH11Y during neuroendocrine differentiation of prostate cancer.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1502405
- By:
- Publication type:
- Article
Salvage Ultrasound-Guided Robot-Assisted Video-Endoscopic Inguinal Lymphadenectomy (RAVEIL) as a Metastasis-Directed Therapy (MDT) in Oligoprogressive Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Case Report and Review of the Literature.
- Published in:
- Current Oncology, 2025, v. 32, n. 2, p. 115, doi. 10.3390/curroncol32020115
- By:
- Publication type:
- Article
RhoB regulates prostate cancer cell proliferation and docetaxel sensitivity via the PI3K-AKT signaling pathway.
- Published in:
- BMC Cancer, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12885-025-13762-4
- By:
- Publication type:
- Article
Unveiling the Potential of Prostate-Specific Membrane Antigen for Precision Diagnosis and Therapy of Prostate Cancer: A Radiopharmaceutical Perspective.
- Published in:
- Malaysian Journal of Medical Sciences, 2024, v. 31, n. 4, p. 213, doi. 10.21315/mjms2024.31.4.17
- By:
- Publication type:
- Article
Accelerating Cellular Uptake with Unnatural Amino Acid for Inhibiting Immunosuppressive Cancer Cells.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 30, p. 1, doi. 10.1002/chem.202400691
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic modeling of the metastin/kisspeptin analog, TAK‐448, for its anti‐tumor efficacy in a rat xenograft model.
- Published in:
- Biopharmaceutics & Drug Disposition, 2020, v. 41, n. 7, p. 283, doi. 10.1002/bdd.2245
- By:
- Publication type:
- Article
How to survey adherence to guidelines by use of clinical cancer registers: Editorial comment to 'Swedish National Guidelines on prostate cancer part I and II' by Bratt et al.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
The Swedish national guidelines on prostate cancer, part 2: recurrent, metastatic and castration resistant disease.
- Published in:
- Scandinavian Journal of Urology, 2022, v. 56, n. 4, p. 278, doi. 10.1080/21681805.2022.2093396
- By:
- Publication type:
- Article
Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists.
- Published in:
- Scandinavian Journal of Urology, 2022, v. 56, n. 3, p. 169, doi. 10.1080/21681805.2022.2070275
- By:
- Publication type:
- Article
Real world treatment utilization patterns in patients with castration-resistant prostate cancer.
- Published in:
- Scandinavian Journal of Urology, 2021, v. 55, n. 4, p. 299, doi. 10.1080/21681805.2021.1936626
- By:
- Publication type:
- Article
Time spent in hormone-sensitive and castration-resistant disease states in men with advanced prostate cancer, and its health economic impact: registry-based study in Sweden.
- Published in:
- Scandinavian Journal of Urology, 2021, v. 55, n. 1, p. 1, doi. 10.1080/21681805.2020.1851762
- By:
- Publication type:
- Article
Role of sparing of puboprostatic ligaments on continence recovery after radical prostatectomy: a randomized controlled trial.
- Published in:
- Scandinavian Journal of Urology, 2021, v. 55, n. 1, p. 22, doi. 10.1080/21681805.2020.1849389
- By:
- Publication type:
- Article
Value of clinical parameters and MRI with PI-RADS<sub>V2</sub> in predicting seminal vesicle invasion of prostate cancer.
- Published in:
- Scandinavian Journal of Urology, 2021, v. 55, n. 1, p. 17, doi. 10.1080/21681805.2020.1833981
- By:
- Publication type:
- Article
Impact of diabetes and metformin use on prostate cancer.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Preexisting diabetes, metformin use and long-term survival in patients with prostate cancer.
- Published in:
- Scandinavian Journal of Urology, 2020, v. 54, n. 5, p. 401, doi. 10.1080/21681805.2020.1798502
- By:
- Publication type:
- Article
The value of a first MRI and targeted biopsies after several years of active surveillance for low-risk prostate cancer – results from the SAMS trial.
- Published in:
- Scandinavian Journal of Urology, 2020, v. 54, n. 4, p. 318, doi. 10.1080/21681805.2020.1788634
- By:
- Publication type:
- Article
Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.
- Published in:
- Scandinavian Journal of Urology, 2020, v. 54, n. 3, p. 215, doi. 10.1080/21681805.2020.1752795
- By:
- Publication type:
- Article
Update on a real-world study evaluating overall survival and treatment duration in Swedish patients with metastatic castration-resistant prostate cancer treated with enzalutamide.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Adherence to guidelines for androgen deprivation therapy after radical prostatectomy: Swedish population-based study.
- Published in:
- Scandinavian Journal of Urology, 2020, v. 54, n. 3, p. 208, doi. 10.1080/21681805.2020.1750475
- By:
- Publication type:
- Article
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden.
- Published in:
- Scandinavian Journal of Urology, 2020, v. 54, n. 2, p. 115, doi. 10.1080/21681805.2020.1739139
- By:
- Publication type:
- Article
Non-metastatic prostate cancer: rationale for conservative treatment and impact on disease-related morbidity and mortality in the elderly.
- Published in:
- Scandinavian Journal of Urology, 2020, v. 54, n. 2, p. 105, doi. 10.1080/21681805.2020.1732463
- By:
- Publication type:
- Article